Chief Development Officer
- Employer
- Shatterproof
- Location
- Connecticut, United States
- Salary
- Competitive Salary
- Closing date
- Apr 24, 2021
View more
- Position Type
- Executive, Fundraising, Fundraising Administration, Major Gifts, Other Fundraising
- Fields
- Health, Research, Social Services, Youth
- Employment Type
- Full Time
The Aspen Leadership Group is proud to partner with Shatterproof
in the search for a Chief Development Officer.
Reporting to the Chief Executive Officer, the Chief Development
Officer, a newly-created senior leadership role at Shatterproof,
will be responsible for fundraising and development activities and
will help establish and nurture relationships that enhance
Shatterproof's financial resources, visibility, and impact. The
Chief Development Officer will evaluate, develop, and implement the
infrastructure needed to expand and diversify Shatterproof's donor
base. The location of this position is flexible with a preference
for the Northeast corridor (access to Washington, DC).
Shatterproof is a national nonprofit dedicated to reversing the
addiction crisis in the United States. Addiction is the most
significant health crisis in the United States today. For the 20.4
million adults in America with a substance use disorder, the
devastation caused by the disease can be crushing. In 2018, more
than 175,000 deaths in the U.S. were related to alcohol and other
drugs – the third largest cause of death in the nation. Of those
deaths, 47,000 were from an opioid overdose. The opioid crisis cost
society an estimated $696 billion in 2018 alone. The impact is felt
across a broad swath of society, from health care to employers to
the government. Even more tragic, the social isolation and anxiety
brought on by COVID-19 has made the addiction crisis that much
worse. Addressing this health crisis is more important now than
ever. Over 81,000 drug overdose deaths occurred in the United
States in the 12 months ending in May 2020, the highest number of
overdose deaths ever recorded in a 12-month period, according to
recent provisional data from the Centers for Disease Control and
Prevention (CDC).
Shatterproof draws from the extensive business experience of its
senior leadership and uses a for-profit, ROI-focused lens to create
results. Its strict commitment to science, evidence-based
solutions, and transformational change has informed the business
plan it executes daily. Shatterproof is transforming the healthcare
delivery system so that every person facing addiction has access to
quality care and treatment based on science. Addiction is a
treatable disease, not a weakness. By changing people’s attitudes
and behaviors, Shatterproof is reducing the shame in order to
encourage patients to seek life-saving treatment, and providing
reassurance, compassion, and support for a full and fulfilling
life. Shatterproof is providing science-based educational resources
that aid in the prevention, treatment, and recovery of addiction,
while building hope, confidence, and resiliency within families and
communities, and advocating for life-saving policies.
Addiction has an impact on all people, but like most health
conditions in the United States, the negative impact of this
disease on Black and Latino communities is disproportionate.
Therefore, Shatterproof denounces racism and is committed to
listening, learning, supporting, and advocating for health equity.
Structural racism underlies the various responses to the phases of
the addiction epidemic in America and it can only be reversed by
taking an anti-racism approach. In the 1980s, when addiction was
perceived as rampant amongst communities of color, the crisis was
met with stigmatizing and discriminatory policies. Now, the opioid
epidemic has reframed addiction as a disease, while simultaneously
whitewashing the response by continuing to ignore the crisis within
communities of color. Despite having higher increases in opioid
overdose deaths tied to fentanyl, Black Americans have
significantly lower access to treatment. For example, white
patients are 35 times more likely than Black patients to receive
buprenorphine, one of the proven medications for treating opioid
use disorder. Eliminating the disparities of these metrics must be
a part of the addiction response.
A bachelor's degree is required for this position as is at least
seven years of fundraising experience with demonstrated success in
a building a development function (managing and forging
relationships with multiple donor sources), preferably in public
health, public policy, and/or substance use disorder treatment on a
national level. All applications must be accompanied by a cover
letter and résumé. Cover letters should be responsive to the
mission of Shatterproof to reverse the addiction crisis in the
United States, help reduce the stigma of addiction, improve
treatment quality and access, and save lives.
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert